Editorial: Aptamer-based structural biology, computational modelling, translational research and drug discovery, Volume II

Yuan Ma; Yuanyuan Yu; Baoting Zhang; Aiping Lu; Ge Zhang

doi:10.3389/fcell.2023.1195372

Editorial: Aptamer-based structural biology, computational modelling, translational research and drug discovery, Volume II

Front Cell Dev Biol. 2023 May 15:11:1195372. doi: 10.3389/fcell.2023.1195372. eCollection 2023.

Authors

Yuan Ma^{1

2}, Yuanyuan Yu^{1

2}, Baoting Zhang³, Aiping Lu^{1

2}, Ge Zhang^{1

2}

Affiliations

¹ Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong SAR, China.
² Institute of Precision Medicine and Innovative Drug Discovery, HKBU Institute for Research and Continuing Education, Shenzhen, China.
³ School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.

No abstract available

Keywords: aptamer; aptamer-drug conjugate (ApDC); delivery system; extend therapeutic half-life; high affinity.

Publication types

Editorial

Grants and funding

This editorial was supported by the Guangdong Basic and Applied Basic Research Foundation (2020A1515110630), and Key-Area R&D Program of Department of Science and Technology of HuNan Province (2022WK2010).